Back to search

Article

Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approach

2020-04-03

Abstract excerpt

The 2019 novel coronavirus (COVID19 / Wuhan coronavirus), officially named as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is a positive-sense single-stranded RNA coronavirus. SARS-CoV-2 causes the contagious COVID19 disease also known as 2019-nCoV acute respiratory disease and has led to the ongoing 2019–20 pandemic COVID19 outbreak. The effective counter measures against SARS-CoV-2 infection req...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
75bdc1cd-f864-58c2-a3e3-2e2c4b2dd248
DOI
10.1101/2020.04.01.019299
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approachDOI 10.1101/2020.04.01.019299
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and ValidationSemantic proximity
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approachesSemantic proximity
Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity
The multi-epitope vaccine prediction to combat Pandemic SARS-CoV-2, an immunoinformatic approachSemantic proximity
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and <i>in silico</i> approachesSemantic proximity
Designing a new multi epitope-based vaccine against COVID-19 disease: an immunoinformatic study based on reverse vaccinology approachSemantic proximity
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity
A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS‐COV‐2 by Comprehensive Immunoinformatic and Molecular Modelling ApproachSemantic proximity
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approachSemantic proximity
A Putative Prophylactic Solution for COVID-19: Development of Novel Multiepitope Vaccine Candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling ApproachSemantic proximity
Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus (SARS-CoV-2)Semantic proximity
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approachSemantic proximity
Select a neighboring publication to make it the new centre.